Published in FEBS Lett on August 03, 1992
Small cysteine-rich antifungal proteins from radish: their role in host defense. Plant Cell (1995) 2.54
A novel pathogen- and wound-inducible tobacco (Nicotiana tabacum) protein with antifungal activity. Plant Physiol (1994) 1.90
A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans. Cell Host Microbe (2011) 1.80
Antifungal proteins. Appl Environ Microbiol (2001) 1.51
The N-terminal cysteine-rich domain of tobacco class I chitinase is essential for chitin binding but not for catalytic or antifungal activity. Plant Physiol (1993) 1.07
Disruption of abscisic acid signaling constitutively activates Arabidopsis resistance to the necrotrophic fungus Plectosphaerella cucumerina. Plant Physiol (2012) 0.99
Barley pathogenesis-related proteins with fungal cell wall lytic activity inhibit the growth of yeasts. Plant Physiol (1993) 0.90
Purification and Characterization of an Endophytic Fungal Proteinase That Is Abundantly Expressed in the Infected Host Grass. Plant Physiol (1994) 0.84
Characterization of a pathogenesis-related protein 4 (PR-4) induced in Capsicum chinense L3 plants with dual RNase and DNase activities. J Exp Bot (2010) 0.82
The sugarcane defense protein SUGARWIN2 causes cell death in Colletotrichum falcatum but not in non-pathogenic fungi. PLoS One (2014) 0.75
Defense-related proteins involved in sugarcane responses to biotic stress. Genet Mol Biol (2017) 0.75
Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun (2000) 3.24
Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study. Clin Pharmacol Ther (2008) 3.23
Modification of the enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum and urine. Clin Chim Acta (1972) 2.92
Plant chitinases. Plant J (1993) 2.88
Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum (1999) 2.66
Induction of heat shock proteins DnaK, GroEL, and GroES by salt stress in Lactococcus lactis. Appl Environ Microbiol (1997) 1.74
Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis, microsequencing and immunodetection. Electrophoresis (2000) 1.74
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis (2008) 1.71
Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest (1995) 1.70
Substrates for plasma kinin-forming enzymes in human, dog and rabbit plasmas. Br J Pharmacol Chemother (1966) 1.56
A new radiological index for assessing asphericity of the femoral head in cam impingement. J Bone Joint Surg Br (2007) 1.54
Two antifungal thaumatin-like proteins from barley grain. FEBS Lett (1991) 1.51
Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies. Ann Rheum Dis (2008) 1.49
How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study. Acta Paediatr Suppl (2004) 1.40
Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect Immun (1998) 1.38
Optimised, low cost, low field dedicated extremity MRI is highly specific and sensitive for synovitis and bone erosions in rheumatoid arthritis wrist and finger joints: comparison with conventional high field MRI and radiography. Ann Rheum Dis (2005) 1.28
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
The prevalence of cam-type deformity of the hip joint: a survey of 4151 subjects of the Copenhagen Osteoarthritis Study. Acta Radiol (2008) 1.27
The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens. Clin Exp Immunol (1995) 1.25
Identification and characterization of a 29-kilodalton protein from Mycobacterium tuberculosis culture filtrate recognized by mouse memory effector cells. Infect Immun (1998) 1.24
Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein. Biochem Pharmacol (1978) 1.23
Fibromyalgia in the adult Danish population: I. A prevalence study. Scand J Rheumatol (1993) 1.22
Silencer region of a chalcone synthase promoter contains multiple binding sites for a factor, SBF-1, closely related to GT-1. Plant Mol Biol (1991) 1.16
Substrates for plasma kinin-forming enzymes in rat and guinea-pig plasma. Br J Pharmacol Chemother (1966) 1.15
Identification of monoclonal antibodies that cross-react with cytokines from different animal species. Vet Immunol Immunopathol (2002) 1.14
Ultrasonography screening for developmental dysplasia of the hip joint. Acta Paediatr (1997) 1.14
Insulin resistance induced by physical inactivity is associated with multiple transcriptional changes in skeletal muscle in young men. Am J Physiol Endocrinol Metab (2010) 1.14
The effect of scalding on the content of kininogen and kininase in limb lymph. Br J Pharmacol Chemother (1966) 1.13
Variable binding of propranolol in human serum. Biochem Pharmacol (1979) 1.12
Separation of 2 different substrates for plasma kinin-forming enzymes. Nature (1966) 1.09
Fibromyalgia in the adult Danish population: II. A study of clinical features. Scand J Rheumatol (1993) 1.07
Total replacement artificial heart and driving system with inherent regulation of cardiac output. Trans Am Soc Artif Intern Organs (1969) 1.05
Cytokinin oxidase or dehydrogenase? Mechanism of cytokinin degradation in cereals. Eur J Biochem (2001) 1.04
Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis. Br J Clin Pharmacol (1983) 1.03
Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor. Eur J Biochem (1996) 1.03
A specific and sensitive assay for aminoguanidine: its application to a study of the disposition of aminoguanidine in animal tissues. J Pharmacol Exp Ther (1969) 1.01
Osteoarthritis of the first carpometacarpal joint: a study of radiology and clinical epidemiology. Results from the Copenhagen Osteoarthritis Study. Osteoarthritis Cartilage (2006) 1.00
SAR pattern perturbations from resonance effects in water bolus layers used with superficial microwave hyperthermia applicators. Int J Hyperthermia (2002) 0.99
Observations on the content of kininogen, kallikrein and kininase in lymph from hind limbs of dogs and rabbits. Br J Pharmacol Chemother (1966) 0.98
Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study. Scand J Rheumatol (2013) 0.98
Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast. FEBS Lett (1993) 0.98
National cohort study of reproductive risk factors for rheumatoid arthritis in Denmark: a role for hyperemesis, gestational hypertension and pre-eclampsia? Ann Rheum Dis (2009) 0.97
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
An acidic class III chitinase in sugar beet: induction by Cercospora beticola, characterization, and expression in transgenic tobacco plants. Mol Plant Microbe Interact (1993) 0.95
Fluorometric determination of hydroflumethiazide in human plasma and urine after its oral administration. Eur J Clin Pharmacol (1977) 0.95
Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma. Biochem Pharmacol (1977) 0.94
The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity. Biochemistry (1991) 0.93
Characterization of a digital microwave radiometry system for noninvasive thermometry using a temperature-controlled homogeneous test load. Phys Med Biol (2008) 0.93
Effect of urine pH and flow on renal clearance of methotrexate. Eur J Clin Pharmacol (1981) 0.93
Purification and characterisation of a malto-oligosaccharide-forming amylase active at high pH from Bacillus clausii BT-21. Carbohydr Res (2000) 0.93
Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA). Clin Exp Immunol (1997) 0.92
Socio-demographic factors, reproductive history and risk of osteoarthritis in a cohort of 4.6 million Danish women and men. Osteoarthritis Cartilage (2011) 0.92
Characterisation of a homogeneous plant aminoaldehyde dehydrogenase. Biochim Biophys Acta (2000) 0.91
Acute phase proteins in cattle after exposure to complex stress. Vet Res Commun (2008) 0.90
Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein. Scand J Clin Lab Invest (2007) 0.89
Ultrasound versus magnetic resonance arthrography in acetabular labral tear diagnostics: a prospective comparison in 20 dysplastic hips. Acta Radiol (2007) 0.89
Characterization of human tissue factor pathway inhibitor variants expressed in Saccharomyces cerevisiae. J Biol Chem (1993) 0.89
Do subjective cognitive complaints correlate with cognitive impairment in systemic lupus erythematosus? A Danish outpatient study. Lupus (2011) 0.89
Effect of leukocyte proteinases on tissue factor pathway inhibitor. Thromb Haemost (1992) 0.89
Breast cancer in systemic lupus erythematosus. Oncology (2013) 0.89
Maintenance therapy with a new retard tablet preparation of procainamide. Am Heart J (1976) 0.88
Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients. Scand J Rheumatol (2012) 0.88
Structure of HBP, a multifunctional protein with a serine proteinase fold. Nat Struct Biol (1997) 0.88
pH lability in serum during equilibrium dialysis. Br J Clin Pharmacol (1985) 0.88
Absence of high-affinity calreticulin autoantibodies in patients with systemic rheumatic diseases and coeliac disease. Scand J Clin Lab Invest (2005) 0.88
A new assay for histaminase activity: measurement of tritiated water from beta (side chain label)-H 3-histamine. J Pharmacol Exp Ther (1971) 0.87
Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis. Scand J Rheumatol (2013) 0.87
High resolution electroelution of polyacrylamide gels for the purification of single proteins from Mycobacterium tuberculosis culture filtrate. Scand J Immunol (2000) 0.86
Distribution of the fungal transposon Restless: full-length and truncated copies in closely related strains. Fungal Genet Biol (1998) 0.85
Binding and endocytosis of proteins mediated by epithelial gp330. Ann N Y Acad Sci (1994) 0.85
A phosphate-starvation-inducible outer-membrane protein of Pseudomonas fluorescens Ag1 as an immunological phosphate-starvation marker. Microbiology (1997) 0.85
Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology (Oxford) (2006) 0.85
The prevalence of fibromyalgia and widespread chronic musculoskeletal pain in the general population. Scand J Rheumatol (1992) 0.84
Localization to chromosomes of structural genes for the major protease inhibitors of barley grains. Theor Appl Genet (1984) 0.84
A new sustained-release tablet formulation of procainamide. Eur J Clin Pharmacol (1973) 0.83
Acute phase protein concentrations in serum and milk from healthy cows, cows with clinical mastitis and cows with extramammary inflammatory conditions. Vet Rec (2004) 0.83
Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients. Lupus (2012) 0.83
Evaluation of an automated assay based on monoclonal anti-human serum amyloid A (SAA) antibodies for measurement of canine, feline, and equine SAA. Vet J (2012) 0.83
Primary structure and specificity of the major serine proteinase inhibitor of amaranth (Amaranthus caudatus L.) seeds. Biochim Biophys Acta (1994) 0.83
High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand J Rheumatol (2005) 0.82
Effect of plasma on human erythrocyte beta-adrenergic receptors. Biochem Pharmacol (1985) 0.82
Synergism between thapsigargin and the phorbol ester 12-O-tetradecanoylphorbol 13-acetate on the release of [14C]arachidonic acid and histamine from rat peritoneal mast cells. Biochem Pharmacol (1987) 0.82
Muscle function and origin of pain in fibromyalgia. Baillieres Clin Rheumatol (1994) 0.82
Determination of autoantibodies to annexin XI in systemic autoimmune diseases. Lupus (2000) 0.82
Ultrasonic measurement of skin thickness in patients with systemic sclerosis. Acta Derm Venereol (2000) 0.81
Recombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical development. Semin Thromb Hemost (2001) 0.81
Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction. Br J Clin Pharmacol (1981) 0.81
Renal cell apoptosis in human lupus nephritis: a histological study. Lupus (2009) 0.81
Some data on two purified kininogens from human plasma. Br J Pharmacol Chemother (1967) 0.81
GlycoPEGylated rFVIIa (N7-GP) has a prolonged hemostatic effect in hemophilic mice compared with rFVIIa. J Thromb Haemost (2011) 0.81
The binding of quinidine to protein fractions of normal human sera. Biochem Pharmacol (1975) 0.81
Isometric and isokinetic muscle strength in patients with fibrositis syndrome. New characteristics for a difficult definable category of patients. Scand J Rheumatol (1987) 0.81
Serpins from wheat grain. FEBS Lett (1994) 0.81
Absolute bioavailability of quinidine in two sustained release preparations. Eur J Clin Pharmacol (1979) 0.80
Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis. Lupus (2009) 0.80